Business Wire

Ankyra Therapeutics Presents First Preclinical Data on ANK-203, a Novel CD137-Anchored Immunotherapy Candidate, in Oral Session at AACR IO

ANK-203 is a first-in-class anchored immunotherapy designed to unlock the full therapeutic potential of monoclonal antibody CD137 through localized delivery and retention In preclinical studies, ...
Indiatimes

Ank Theatre revives Agha Hashar Kashmiri’s classic Sita Banbas

Mumbai's Ank Theatre, nearing its 50th year, presents Agha Hashar Kashmiri's 'Sita Banbas' at Prithvi Theatre. Director Atul Tiwari describes the play as a powerful exploration of Ram and Sita's ...
Business Wire

Anokion Announces New Data from the Phase 1 MoveS-it Study Supporting ANK-700 as a Novel, Potential Disease Modifying Treatment for Relapsing-Remitting Multiple Sclerosis

CAMBRIDGE, Mass. & LAUSANNE, Switzerland--(BUSINESS WIRE)--Anokion SA, a clinical-stage biotechnology company focused on treating autoimmune disease by restoring normal immune tolerance, today ...
PharmiWeb

Anokion Announces Clinical Progress with KAN-101 and ANK-700

Phase 2 Dosing Initiated in the Global Phase 1b/2 ACeD-it Clinical Trial of KAN-101 for the Treatment of Celiac Disease; Data Expected in 2024 On-track to Initiate Global Phase 2a SynCeD Histological ...
Hindustan Times

Diwali Ank: Celebration of words and lights gets another festive cover

Pune: As festive lights brighten homes across Maharashtra, another vibrant Diwali tradition quietly illuminates the minds — special magazines known as Diwali Ank, Marathi literature’s enduring gift to ...